Dextrose 5% in water
Dextrose 5% in water is a pharmaceutical drug with 14 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
1
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
10 of 10 finished
0.0%
0 ended early
2
trials recruiting
14
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants
Tranexamic Acid as an Intervention in Abruptio Placenta
Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction in Patients With Severe Hypernatremia
Ketamine and Lidocaine Infusion in Refractory Chronic Migraine
The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome
Clinical Trials (14)
A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants
Tranexamic Acid as an Intervention in Abruptio Placenta
Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction in Patients With Severe Hypernatremia
Ketamine and Lidocaine Infusion in Refractory Chronic Migraine
The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome
Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study
Comparison of Ultrasound-Guided Perimeniscal Steroid and 5% Dextrose Injections in Knee Osteoarthritis
Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis
Low and High Dose Dextrose Prolotherapy in the Treatment of Lateral Epicondylitis
Corticosteroid and Repeated Dextrose Hydro-dissection for Carpal Tunnel Syndrome Patients
Dextrose Effect on Postoperative Nausea and Vomiting (PONV)
Intrathecal Neostigmine for Prevention of PDPH
Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)
Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
All 14 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 14